Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial-Reference-Cited by-同舟云学术

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial

Published:2019-09 Issue:9 Volume:20 Page:1306-1315
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Friedlander Michael,Meniawy Tarek,Markman Ben,Mileshkin Linda,Harnett Paul,Millward Michael,Lundy Joanne,Freimund Alison,Norris Christie,Mu Song,Wu John,Paton Virginia,Gao Bo

Publisher

Elsevier BV

Subject

Oncology

Reference28 articles.

1. The DNA damage response, immunity and cancer;Gasser;Semin Cancer Biol,2006

2. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer;Strickland;Oncotarget,2016

3. NKG2D ligands in tumor immunity;Nausch;Oncogene,2008

4. DNA repair deficiency and immunotherapy response;Mouw;J Clin Oncol,2018

5. PARP inhibitor upregulates PD-L1 expression and enhances cancer-associated immunosuppression;Jiao;Clin Cancer Res,2017

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study;Translational Oncology;2024-10

2. Advancements in second-line treatment research for hepatocellular carcinoma;Clinical and Translational Oncology;2024-08-20

3. Exploring treatment options in cancer: tumor treatment strategies;Signal Transduction and Targeted Therapy;2024-07-17

4. Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors;Cancer Medicine;2024-07

5. Pyrrole-containing hybrids as potential anticancer agents: An insight into current developments and structure-activity relationships;European Journal of Medicinal Chemistry;2024-07